V Pierrat1, N Haouari, A Liska, D Thomas, D Subtil, P Truffert. 1. Service de Médicine Néonatale, CHRU de Lille, Hôpital Jeanne de Flandre, 2 av O Lambret, 59037 Lille Cedex, France. vpierrat@chru-lille.fr
Abstract
OBJECTIVES: To ascertain the prevalence of newborn encephalopathy in term live births, and also the underlying diagnoses, timing, and outcome at 2 years of surviving infants. DESIGN: Population based observational study. SETTING: North Pas-de-Calais area of France, January to December 2000. PATIENTS: All 90 neonates with moderate or severe newborn encephalopathy. RESULTS: The prevalence of moderate or severe newborn encephalopathy was 1.64 per 1000 term live births (95% confidence interval (CI) 1.30 to 1.98). The prevalence of birth asphyxia was 0.86 per 1000 term live births (95% CI 0.61 to 1.10). The main cause of newborn encephalopathy was birth asphyxia, diagnosed in 47 (52%) infants. It was associated with another diagnosis in 11/47 cases (23%). The timing was intrapartum in 56% of cases, antepartum in 13%, ante-intrapartum in 10%, and postpartum in 2%. In 19% of cases, no underlying cause was identified during the neonatal course. Twenty four infants died in the neonatal period, giving a fatality rate of 27% (95% CI 17% to 36%). Three infants died after the neonatal period. At 2 years of age, 38 infants had a poor outcome, defined by death or severe disability, a prevalence of 0.69 per 1000 term live births (95% CI 0.47 to 0.91). In infants with isolated birth asphyxia, this prevalence was 0.36 per 1000 term live births (95% CI 0.20 to 0.52). CONCLUSIONS: The causes of newborn encephalopathy were heterogeneous but the main one was birth asphyxia. The prevalence was low, but the outcome was poor, emphasising the need for prevention programmes and new therapeutic approaches.
OBJECTIVES: To ascertain the prevalence of newborn encephalopathy in term live births, and also the underlying diagnoses, timing, and outcome at 2 years of surviving infants. DESIGN: Population based observational study. SETTING: North Pas-de-Calais area of France, January to December 2000. PATIENTS: All 90 neonates with moderate or severe newborn encephalopathy. RESULTS: The prevalence of moderate or severe newborn encephalopathy was 1.64 per 1000 term live births (95% confidence interval (CI) 1.30 to 1.98). The prevalence of birth asphyxia was 0.86 per 1000 term live births (95% CI 0.61 to 1.10). The main cause of newborn encephalopathy was birth asphyxia, diagnosed in 47 (52%) infants. It was associated with another diagnosis in 11/47 cases (23%). The timing was intrapartum in 56% of cases, antepartum in 13%, ante-intrapartum in 10%, and postpartum in 2%. In 19% of cases, no underlying cause was identified during the neonatal course. Twenty four infants died in the neonatal period, giving a fatality rate of 27% (95% CI 17% to 36%). Three infants died after the neonatal period. At 2 years of age, 38 infants had a poor outcome, defined by death or severe disability, a prevalence of 0.69 per 1000 term live births (95% CI 0.47 to 0.91). In infants with isolated birth asphyxia, this prevalence was 0.36 per 1000 term live births (95% CI 0.20 to 0.52). CONCLUSIONS: The causes of newborn encephalopathy were heterogeneous but the main one was birth asphyxia. The prevalence was low, but the outcome was poor, emphasising the need for prevention programmes and new therapeutic approaches.
Authors: Frances Cowan; Mary Rutherford; Floris Groenendaal; Paula Eken; Eugenio Mercuri; Graeme M Bydder; Linda C Meiners; Lilly M S Dubowitz; Linda S de Vries Journal: Lancet Date: 2003-03-01 Impact factor: 79.321
Authors: Hari Eswaran; Rathinaswamy B Govindan; Naim I Haddad; Eric R Siegel; Hubert T Preissl; Pamela Murphy; Curtis L Lowery Journal: Early Hum Dev Date: 2011-10-05 Impact factor: 2.079
Authors: Jan L Wallander; Carla Bann; Elwyn Chomba; Shivaprasad S Goudar; Omrana Pasha; Fred J Biasini; Elizabeth M McClure; Vanessa Thorsten; Dennis Wallace; Waldemar A Carlo Journal: Early Hum Dev Date: 2014-05-09 Impact factor: 2.079
Authors: Jan L Wallander; Elizabeth McClure; Fred Biasini; Shivaprasad S Goudar; Omrana Pasha; Elwyn Chomba; Darlene Shearer; Linda Wright; Vanessa Thorsten; Hrishikesh Chakraborty; Sangappa M Dhaded; Niranjana S Mahantshetti; Roopa M Bellad; Zahid Abbasi; Waldemar Carlo Journal: BMC Pediatr Date: 2010-04-30 Impact factor: 2.125
Authors: Karin B Nelson; Peter Bingham; Erika M Edwards; Jeffrey D Horbar; Michael J Kenny; Terrie Inder; Robert H Pfister; Tonse Raju; Roger F Soll Journal: Pediatrics Date: 2012-10-15 Impact factor: 7.124